Multidrug-resistant bacteria in lung transplantation.
Multidrug-resistant bacteria in lung transplantation.
Curr Opin Organ Transplant. 2020 Jun 30;:
Authors: Dominguez F, Blodget E
Abstract
PURPOSE OF REVIEW: The review of infections in lung transplantation is beyond the scope of this article as it is a comprehensive topic, however we aim to focus on infections with multidrug-resistant (MDR) microorganisms in this patient population.
RECENT FINDINGS: New emerging clinical studies have provided data regarding outcomes in lung transplant recipients with MDR bacterial infections.
SUMMARY: Isolation of MDR bacteria from lung donors preoperatively has not been associated with worse outcomes in recipients. Patients with cystic fibrosis colonized with MDR bacteria do not have increased 1 year mortality rates compared to those without MDR bacteria.
PMID: 32618718 [PubMed - as supplied by publisher]
Source: Current Opinion in Organ Transplantation - Category: Transplant Surgery Authors: Dominguez F, Blodget E Tags: Curr Opin Organ Transplant Source Type: research
More News: Cystic Fibrosis | Lung Transplant | Multidrug Resistance | Study | Transplant Surgery | Transplants